| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7a0c49e4b9499de007d9dc1d6728bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a2c561351f0adaecce09f8ee9ad646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecde9773eca0d9c6e71d2cd1985d2cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6283a3dd457eab088e37f97d13bea7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf43c580be7d226940b261ecfa355a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35410527cd66ce58ca027b80951952da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375272abfaf6ea503e5d3036bebd3c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4edd8d6f33e96cde2b0b8fe14691cf0f |
| publicationDate |
2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2840719-A1 |
| titleOfInvention |
Antagonist peptide of the bond between cd47 and a protein belonging to the thrombospondin family |
| abstract |
The invention relates to a peptide antagonizing the binding between a cellular receptor, CD47, and a protein belonging to the thrombospondin family (TSP). The peptide according to the present invention has the SI sequence R1-R2-R3-SQLLKG-R4-R5-R6 and specifically interacts with the C-terminus of the TSP, at the binding site between said TSP and said CD47 receptor , so as to prevent an interaction between said CD47 receptor and said protein. The peptide according to the present invention can be used in the context of cancer treatments. |
| priorityDate |
2011-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |